Bibliographic record and links to related information available from the Library of Congress catalog.
Note: Contents data are machine generated based on pre-publication provided by the publisher. Contents may have variations from the printed book or be incomplete or contain other coding.
Contents Acknowledgements Preface List of Abbreviations Table of Cases Part I: The problem - Access as a necessary element of follow-on innovation? 1. Biopharmaceutical R&D: The increased importance of cumulative innovation and related concerns Part II: The Patent Balance & Working Solutions in the Patent System 2. The patent system as a system of balancing 3. The Patent System and Some Potential Safety Nets 4. The Right to Health as an Interpretive Principle of Patent Law PART III: Antitrust as a Complement to the Patent System 5. Unilateral conduct, IPRs and Competition Law: A Systems' Interaction 6. The Duty to Deal under Art. 82 EC PART IV: A MORE INNOVATION SENSITIVE APPROACH TO THE INTERFACE OF COMPETITION LAW & PATENTS? 7. The Duty to Deal as Applied to Address Technology Access Problems in the Biopharmaceutical Industry Bibliography Index
Library of Congress Subject Headings for this publication:
Patent laws and legislation.
Pharmaceutical biotechnology -- Patents.
Pharmaceutical biotechnology -- Law and legislation.